safinamide has been researched along with Cholera Infantum in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnold, G; Bonuccelli, U; Cattaneo, C; Fariello, RG; Kwiecinski, H; Onofrj, M; Sala, P; Stocchi, F; Szczudlik, A; Thomas, A; Van Dijk, A | 1 |
1 trial(s) available for safinamide and Cholera Infantum
Article | Year |
---|---|
Improvement of motor function in early Parkinson disease by safinamide.
Topics: Adult; Aged; Alanine; Antiparkinson Agents; Benzylamines; Calcium Channel Blockers; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Gastrointestinal Diseases; Glutamic Acid; Humans; Male; Middle Aged; Motor Activity; Neuroprotective Agents; Parkinson Disease; Sodium Channel Blockers; Treatment Outcome | 2004 |